ranitidine has been researched along with Cancer of Gastrointestinal Tract in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 4 (66.67) | 2.80 |
Authors | Studies |
---|---|
Adami, HO; Chang, ET; Heide-Jørgensen, U; Nørgaard, M; Sørensen, HT; Trolle Andersen, I | 1 |
Adami, HO; Andersen, IT; Heide-Jørgensen, U; Nørgaard, M; Sørensen, HT | 1 |
Karp, I | 1 |
Fass, R; Ganocy, SJ; Kim, YD; Poels, KE; Shibli, F; Wang, J | 1 |
Hsu, K; Lankarani-Fard, A; Murphy, MC; Prommer, E | 1 |
Colin-Jones, DG; Langman, MJ; Lawson, DH; Vessey, MP | 1 |
1 review(s) available for ranitidine and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
Pharmacologic Management of Malignant Bowel Obstruction: When Surgery Is Not an Option.
Topics: Anti-Inflammatory Agents; Anti-Ulcer Agents; Dexamethasone; Gastrointestinal Neoplasms; Histamine H2 Antagonists; Hospitalists; Humans; Intestinal Obstruction; Palliative Care; Patient Care Team; Ranitidine | 2019 |
5 other study(ies) available for ranitidine and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
Ranitidine Use and Risk of Upper Gastrointestinal Cancers.
Topics: Adult; Case-Control Studies; Denmark; Dimethylnitrosamine; Female; Gastrointestinal Neoplasms; Histamine H2 Antagonists; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Ranitidine; Registries | 2021 |
Ranitidine Use and Risk of Upper Gastrointestinal Cancers-Reply.
Topics: Gastrointestinal Neoplasms; Humans; Ranitidine; Upper Gastrointestinal Tract | 2022 |
"Ranitidine Use and Risk of Upper Gastrointestinal Cancers"-Letter.
Topics: Gastrointestinal Neoplasms; Humans; Ranitidine; Upper Gastrointestinal Tract | 2022 |
No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies.
Topics: Animals; Famotidine; Gastroesophageal Reflux; Gastrointestinal Neoplasms; Humans; Omeprazole; Ranitidine; United States | 2021 |
Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up.
Topics: Aged; Cimetidine; Duodenal Ulcer; Evaluation Studies as Topic; Female; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrhage; Product Surveillance, Postmarketing; Ranitidine; Respiratory Tract Neoplasms; Risk; United Kingdom; Urologic Diseases | 1985 |